Geistlich UK is the UK affiliate for Geistlich Pharma AG, specializing in the production and distribution of medical devices and drugs for regenerative medicine. With a history dating back to 1851, this Swiss company has established itself as a global leader in regenerative dentistry through its business unit Geistlich Biomaterials, backed by an extensive portfolio of pre-clinical and clinical studies. The company's flagship products, Geistlich Bio-Oss® and Geistlich Bio-Gide®, have demonstrated remarkable success in practice, attributed to their exceptional biofunctionality.
Geistlich Pharma AG, with its three business units and nine subsidiaries, has a significant global presence, employing around 450 employees worldwide. The company's continued focus on innovation and superior product handling, exemplified by Geistlich Bio-Oss® Collagen and Geistlich Bio-Oss® Pen, has solidified its position as the premier supplier of biomaterials globally.
Founded in 1960, Geistlich UK operates within the Medical Devices industry and is poised to capitalize on the growing demand for regenerative medicine solutions. Although specific details about the company's last investment and the involved investors are not available, Geistlich UK's pioneering advancements in regenerative dentistry position it as an attractive investment opportunity in the evolving healthcare landscape.
There is no investment information
No recent news or press coverage available for Geistlich UK.
We care about your data, and we'd love to use cookies make your experience better.
